Unit 5 - Respiratory Disorders

Lung Compliance

  • Ability of lungs to stretch and expand

Low = More work needed to inflate
High = Hard to expel air out

Factors Influencing Ventilation (SNS & PNS)
Low O2 demands

  • PNS when demand is low
  • Vagus nerve secretes Ach --> stimulates bronchial smooth muscle --> decreases airway radies (bronchconstriction)

High O2 demands

  • SNS when demand is increased
  • Norepinephrine & epinephrine from adrenal medulla --> stimulates beta 2 receptors on bronchial smooth muscles --> increase airway radii (bronchodilation)

Geriatric Considerations

  • Reduced elastin and increased collagen
  • Decreased elastic recoil d/t rib & cartilage calcification
  • Less strength of diaphragm, intercostal muscles, and accessory muscles
  • Cilia loss with reduced cough power
  • Reduced pulmonary blood flow
  • All increase work of breathing

Alterations in Pulmonary Function

  • Hypoxemia
  • Hypoxia
  • Hypercapnia
  • Hypocapnia

Hypercapnia

  • Aka hypercarbia
  • Increased blood CO2
  • Inversely related to ventilation
  • Severe hypoventilation has hypoxemia and hypercapnia

Causes

  • Hypoventilation
  • Lung disease
  • Decrease LOC
  • Rebreathing CO2

Clinical Manifestations

  • Increased PO2 --> Increased H+ --> Decreased pH blood = Respiratory Acidosis
  • Kidneys compensate by increasing H+ excretion and HCO3- retention
  • Chronic hypercapnia doesn't show S&S until PCO2 is greatly elevated or PO2 is greatly reduced

Hypocapnia

  • Low PCO2
  • From hyperventilation

Causes:

  • Pain, fever, anxiety, sepsis
  • High altitude
  • Brainstem injury

Hypoxemia

  • Reduced blood oxygen levels (PO2), leading to hypoxia

Causes:

  • Hypoventilation
  • Obstruction
  • Inadequate amount of O2 in air
  • Altered circulatory function
  • Neurological dysfunction
    • Decreased LOC/euphoria
  • Obesity
    • Obstructive sleep apnea (OSA)

Clinical Manifestations

  • SNS compensation of shunting
  • CNS effects:
    • Slight impairment of mental performance/euphoria
    • Agitation, confusion, impaired judgment
  • Pulmonary vasoconstriction
    • Increased pulmonary arterial pressure to increase perfusion
    • Increased production of erythrocytes
  • Cyanosis

Ventilation Perfusion Ratio (V/Q Ratio)

  • Volume of air (V) in alveoli matches blood flow (Q) for adequate diffusion

Normal:

  • 4ml/5ml = 0.8

Under-perfusion V/Q

  • Under-perfused
  • Adequate ventilation but inadequate perfusion
  • Abnormal pulmonary blood flow
    • Pulmonary embolus, heart failure, hypotension

High V/Q Ratio
4ml/ <5ml = >0.8


Physiological Dead Space

Under-ventilated V/Q

  • Under-ventilated
  • Adequate perfusion but inadequate ventilation
  • Alveolar collapse/consolidation, obstruction

Low V/Q Ratio
4ml/ >5ml = <0.8


Shunt

Deep Vein Thrombosis (DVT)
3 Factors (Virchow's Triad)

  • Venous stasis/slow blood
    • From immobility, trauma, pregnancy, obstetric surgery, cancer, and estrogen use
    • 50% idiopathic
  • Hypercoagulability
  • Damage to the venous wall

Clinical Manifestations

  • Warm, painful, swollen, edematous, red

Pulmonary Embolus

  • Traveled DVT blood clot that obstructs pulmonary blood flow

Causes:

  • 90% from deep veins in pelvis or legs
  • Air from IV infusion
  • Fat from broken bone marrow
  • Amniotic fluid entering maternal circulation at delivery


  • Mortality rate = >30% with big PE

  • Under-perfusion V/Q mismatch

Clinical Manifestations

  • Obstruction --> reflexive bronchoconstriction --> Poor ventilation & diffusion --> Loss of surfactant
  • Depends on size of thrombus
  • Restlessness, anxiety
  • Increased HR & RR, dyspnea
  • Chest pain
  • Hemoptysis
  • Hypoxemia
  • Usually undetected unless it's a massive PE

Treatment & Prevention

  • Mobilize patients and teach lower leg movements (q1h, per hour)
  • Anti-coagulants, active ROM, compression hose w/pneumatic compression
  • If confirmed DVT/PE, anticoagulants, thrombolytics, oxygen, bed rest

DON'T RUB IT

Obstructive Airway Disorders

Asthma

  • Chronic inflammation disorder of the airways
  • Bronchial hyper-responsiveness to stimuli with airway inflammation and obstruction

1. Extrinsic (Atopic)

  • Type 1 hypersensitivity reaction from extrinsic allergen
  • Allergy disorder (childhood onset with genetic link)

2. Intrinsic (Nonatopic)

  • Respiratory infection
  • Emotional factors
  • Cold air
  • Exercise
  • GERD/strong odours
  • Drugs/chemicals
  • Smoke/air pollution

Pathophysiology (Atopic Asthma)


Acute Phase (10-20 min after contact with allergen)

  • Antigens bind to presensitized mast cells on mucosal surface of airways
  • Chemical mediators released resulting in mucous production and bronchospasm from stimulation from PNS receptors on airway surface

Late Phase (4-8 hours)

  • Release of inflammatory mediators from mast cells, macrophages, and epithelial cells, leading to migration of other inflammatory cells
  • Changes in mucociliary function and epithelial edema and injury
  • Respiratory tract clearance of secretions decreases
  • Airway responsiveness increases to hypersensitivity
  • Chronic inflammation --> Airway remodeling & airflow limitations

Pathopyshiology (Exercise-Induced)

  • Common in children and adolescents
  • Bronchospasm occurs within minutes of exercise
    • Resolves in an hour
  • Heat & water loss activates inflammatory mechanisms
    • Mediator release from basophils & tissue mast cells
    • Leads to bronchoconstrction

Clinical Manifestations of Asthma


Acute episode

  • Dyspnea, orthopnea (flat dyspnea) with dry/productive cough
  • Hypoxemia
  • Decreased ventilation with wheezing, chest tightness, accessory muscle use
    • Increased O2 demands = Increased WOB (work of breathing)
  • Under-ventilation V/Q


  • May be symptom free between attacks

  • Nocturnal asthma
  • Status asthmaticus

Treatment & Prevention

  • Avoid triggers
  • Annual influenza vaccine
  • Fast-acting medications to alleviate acute attacks
  • Early treatment for respiratory infections
  • Longer-acting inhaled corticosteroids inhaled daily

Chronic Obstructive Pulmonary Disease (COPD)

  • Consists of Crhonic Bronchitis + Emphysema

1. Chronic Obstructive Bronchitis

  • Obstruction of small airways d/t inflammation
  • Irritation by smoking and recurrent infections
  • Hypertrophy of mucous gland

2. Emphysema

  • Enlargement of air spaces, destruction of lung tissue and loss of lung elasticity

1, Chronic Bronchitis
Diagnosed by:

  • Hypersecretion of bronchiol mucous
  • Hypertrophy of submucosal glands in trachea and bronchi
  • Chronic or recurrent productive cough >3 months duration for >2 successive years


  • Persistent, irreversible
  • Male:Female = 1:2

Etiology

  • Smoking (90%)
  • Repeated airway infections & genetics
  • Physical/chemical irritants

Pathophysiology

  • Irritants activate neutrophils
    • Chronic airway inflammation and obstruction of major & small airways
    • Leads to swelling of bronchial mucosa & alveoli, resulting in scarring, fibrosis, increased wall thickness, mucous, and mucous plugs
  • Airway narrowed & proper oxygenation prevented
    • Chronic hypoxia & hypercapnia, leading to pulmonary vessel vasoconstriction
    • Under-ventilation V/Q mismatch
  • Impaired or absent cilia
  • Colonized with H.influenza (bacterial, not flu) and S.pneumoniae

Clinical Manifestations

  • Peripheral edema
  • Digital clubbing
  • Polycythemia (increased RBC abnormally)
  • Recurrent cough/sputum
  • Cyanosis

2. Emphysema

  • Damaged distal alveoli
  • Progressive over long time

Etiology

  • Smoking
  • Air pollution
  • Certain occupations
  • Alpha1-Antitrypsin deficiency (if patients <50 years old)

Pathophysiology

  • Irritants stimulate inflammatory cells into the lungs
    • Increase in proteases release, which destroy elastin
  • DIstal alveoli enlarged & damaged
    • Loss of elastic tissue in lung
    • Loss of radial traction (normally holds airway open)
    • Alveolar collapse with air trapping
  • Loss of elastic alveolar wall and air trapping leads to bullae (large thin-walled cysts in the lung) forming

Clinical Manifestations

  • Thin, pink
  • Airways collapse during exhalation
    • Forced exhalation
    • Pursed-lips and accessory muscles
  • Minimal or absent cough
  • Barrel chest with CO2 retention

Clinical Manifestations for COPD

  • History of smoking
  • Laboured breathing (air hunger)
  • Accessory muscle use
  • Hypoxemia/hypercapnia
  • Right sided heart failure (cor pulmonale)
    • Increased thoracic pressures --> RV afterload increases --> R heart failure
  • Frequent pulmonary infections
  • Gradual, progressive, with frequent exacerbations
  • Ultimately develop respiratory failure

Atelectasis

  • Incomplete expansion of lung
  • Primary in premature neonates
    • Lung lacks surfactant or hasn't been inflated
      Secondary in adults
    • Airway obstruction
    • Mucous plug, increased secretions, collapsing airway
    • Increases after surgery
      • Pain, anaesthesia, immobility promotes retention of bronchial secretions
  • Crompression from tumour, fluid, blood

Clinical Manifestations & Prevention (Secondary)

  • Decreased or no breath sounds
  • Increased RR, dyspnea, cyanosis, hypoxemia, intercostal retractions
  • Pneumonia risk
  • Reduce airway obstruction and re-inflate akveoli

Prevention

  • Ambulation
  • Deep breathing and coughing
  • Positiioning
  • Incentive spirometer q1h

COPD Treatment & Prevention
Prevention

  • Adequate rest & hydration
  • Physical reconditioning
  • Influenza and pneumococcal vaccines
  • Smoking cessation

Treatment

  • Low dose O2 therapy
    • SaO2 86-90%
      -Medications
    • Inhaled Beta2 agonists & anticholinergic agents
    • Cough suppressants
    • Antimicrobial agents (infections)

Pneumonia

  • Inflammation of alveoli and bronchioles from infectious/non-infectious agents
    High-risk:
  • Less than 2 years & >65 years of age
  • Diminished gag reflex
  • Seriously ill patients
  • Hypoxic patients and immunocompromised patients

Etiology

  • Aspiration of oro-pharyngeal secretions with normal flora/gastric contents (25-35%)
  • Inhalation of contaminants
  • Contamination from circulatory system

Pathophysiology

  • Organisms enter lung, grow, trigger inflammation
  • Invades alveolar septa
  • Alveolar spaces fill with exudative fluid
  • Consolidates and difficult to expectorate
  • No exudative fluids with viral pneumonia

Community Acquired

  • Bacterial/Viral
  • Commonly S.pneumoniae
  • Could be admitted to hospital

Hospital Acquired

  • Mostly bacterial (P.aeruginosa, S,aureus, E.coli)
  • 2nd most common hospital acquired infection
  • 60% mortality rate

Clinical Manifestations

  • Productive cough with pus and phlegm (sputum)
  • Fever and chills
  • General discomfort, unease, ill feelings (malaise)
  • Loss of appetite with N&A
  • Sharp chest pains that get worse with breathing/coughing
  • SOB
  • Hypotension & tachycardia

Prevention

  • Infection control
  • HOB 30-45 degrees
  • Feed upright
  • Oral care
  • Promote adequate nutrition
  • Limit visitors

Pneumothorax

  • Accumulation of air in pleural space

1. Spontaneous

  • Rupture of bleb or lesion on lung surface
  • Primary: Occurs in healthy, tall, thin men w/o risk factors
  • Secondary: In people with COPD and other lung diseases
  • Alveolar pressure > pleural pressure = aur flows from alveoli to pleural space --> collapse of lung

2. Traumatic

  • From penetrating or blunt chest injuries
  • Commonly dislocated ribs or central line insertion

3. Tension

  • Trauma where intrapleural pressure > atmospheric pressure
  • Air enters pleural space during inspiration but can't leave (trapdoor)
  • Air builds up in pleural space --> lung on ipsilateral (same) side collapses
  • Forces mediastinum toward contralateral (opposite) side
  • Compresses vena cava
    • Decrease venous return and cardiac output

Hemothorax

  • Collection of blood
  • Rupture of big vessel, like an aortic aneurysm
  • Chest surgery

Clinical Manifestations

  • Chest pain & tachypnea
  • Dyspnea with cough
  • Hypotension with tachycardia
  • Hypoxemia with O2 desaturation
    On examination:
  • Midline shift (mediastinal shift)
  • Absent breath sounds on side of collapse

Treatment

  • Chest tube drainage with suction to let air escape without re-entry
  • Supplemental O2

Pleural Effusion

  • Normal: Fluid enters from capillaries in parietal pleura or small holes from diaphragm which is removed by lymphatics in parietal pleura


  • Abnormal collection of fluid in pleural cavity d/t:
    • Rate of fluid formation > rate of removal

Etiology

  • Heart/renal/liver failure
  • Malignancy

Empyema

  • Contains pus, glucose, proteins, leukocytes
  • Infections/abscess in pleural cavity that ruptures


  • Transudative effusion (CHF, hypoproteinemia)

  • Exudative effusion
    • Protein rich with inflammation
    • In TB, malignancies, immune disorders, infections

Needs thoracentesis